Carprovet (Carprofen) Chewable Tablets for Dogs

Description

Carprovet Chewable Tablets are indicated for the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.

Benefits

• Helps manage pain so your dog can get back to doing the activities they enjoy
• Beef-flavored chewable tablets are tasty and easy to administer

Consult with your veterinarian for proper dosage and course of treatment.

Warnings

For use in dogs only. Do not use in cats. All dogs should undergo a thorough history and physical examination before initiation of NSAID therapy. Appropriate laboratory tests to establish hematological and serum biochemical baseline data prior to, and periodically during, administration of any NSAID should be considered. Owners should be advised to observe for signs of potential drug toxicity.

Precautions

As a class, cyclooxygenase inhibitory NSAIDs may be associated with gastrointestinal, renal and hepatic toxicity. Effects may result from decreased prostaglandin production and inhibition of the enzyme cyclooxygenase which is responsible for the formation of prostaglandins from arachidonic acid. When NSAIDs inhibit prostaglandins that cause inammation they may also inhibit those prostaglandins which maintain normal homeostatic function. These anti-prostaglandin effects may result in clinically significant disease in patients with underlying or pre-existing disease more often than in healthy patients. NSAID therapy could unmask occult disease which has previously been undiagnosed due to the absence of apparent clinical signs. Patients with underlying renal disease for example, may experience exacerbation or decompensation of their renal disease while on NSAID therapy. The use of parenteral fluids during surgery should be considered to reduce the potential risk of renal complications when using NSAIDs perioperatively.

Carprovet is not recommended for use in dogs with bleeding disorders (e.g. Von Willebrand’s disease), as safety has not been established in dogs with these disorders. The safe use of Carprovet in animals less than 6 weeks of age, pregnant dogs, dogs used for breeding purposes, or in lactating bitches has not been established.

Food and Drug Interactions

Concurrent administration of potentially nephrotoxic drugs should be approached cautiously, with appropriate monitoring. Concomitant use of Carprovet with other anti-inflammatory drugs, such as other NSAIDs or corticosteroids, should be avoided because of the potential increase of adverse reactions, including gastrointestinal ulcerations and/or perforations. Studies to determine the activity of Carprovet when administered concomitantly with other protein-bound or similarly metabolized drugs have not been conducted. Drug compatibility should be monitored closely in patients requiring additional therapy. Such drugs commonly used include cardiac, anticonvulsant and behavioral medications. It has been suggested that treatment with carprofen may reduce the level of inhalant anesthetics needed. If additional pain medication is warranted after administration of the total daily dose of Carprovet, alternative analgesia should be considered. The use of another NSAID is not recommended. Consider appropriate washout times when switching from one NSAID to another or when switching from corticosteroid use to NSAID use.

Human Warnings

Keep out of reach of children. Not for human use. Consult a physician in cases of accidental ingestion by humans.

Possible Side Effects

Carprofen is an NSAID, and as with others in that class, adverse reactions may occur with its use. The most frequently reported effects have been gastrointestinal signs. Events involving suspected renal, hematologic, neurologic, dermatologic, and hepatic effects have also been reported. Patients at greatest risk for renal toxicity are those that are dehydrated, on concomitant diuretic therapy, or those with renal, cardiovascular, and/or hepatic dysfunction.

Sensitivity to drug-associated adverse reactions varies with the individual patient. Dogs that have experienced adverse reactions from one NSAID may experience adverse reactions from another NSAID.

Contact your veterinarian if you believe your pet is experiencing side effects.

Product Administration

Oral

Product Form

Chewable Tablet

Ingredients

Carprofen

Storage

Store at controlled room temperature 20°-25° C (68°-77° F) with excursions between 15°-30°C (59°-86° F) permitted

Manufacturer

Dechra

Prescribing Info/Brochures

• https://www.dechra-us.com/Files/Files/SupportMaterialDownloads/us/05PG-CAR50060-0117.pdf